Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 4
1929 5
1930 3
1931 5
1932 3
1934 2
1936 7
1937 3
1938 2
1941 1
1945 24
1946 48
1947 74
1948 161
1949 130
1950 220
1951 252
1952 318
1953 265
1954 286
1955 269
1956 254
1957 250
1958 163
1959 99
1960 105
1961 115
1962 140
1963 222
1964 304
1965 206
1966 202
1967 263
1968 309
1969 249
1970 291
1971 348
1972 268
1973 392
1974 417
1975 511
1976 596
1977 533
1978 545
1979 508
1980 384
1981 386
1982 481
1983 392
1984 369
1985 316
1986 407
1987 292
1988 322
1989 423
1990 409
1991 410
1992 438
1993 409
1994 440
1995 450
1996 435
1997 429
1998 400
1999 467
2000 537
2001 508
2002 500
2003 468
2004 504
2005 580
2006 600
2007 641
2008 664
2009 676
2010 674
2011 712
2012 719
2013 758
2014 771
2015 806
2016 782
2017 696
2018 732
2019 779
2020 1167
2021 1211
2022 1059
2023 971
2024 400

Text availability

Article attribute

Article type

Publication date

Search Results

33,553 results

Results by year

Filters applied: . Clear all
Page 1
BCG vaccination strategies against tuberculosis: updates and perspectives.
Qu M, Zhou X, Li H. Qu M, et al. Hum Vaccin Immunother. 2021 Dec 2;17(12):5284-5295. doi: 10.1080/21645515.2021.2007711. Epub 2021 Dec 2. Hum Vaccin Immunother. 2021. PMID: 34856853 Free PMC article. Review.
In the absence of other approved vaccines, it is also necessary to improve the efficacy of BCG itself. Intravenous (IV) BCG administration and BCG revaccination strategies have recently shown promising results for clinical usage. Therefore, it is necessary fo …
In the absence of other approved vaccines, it is also necessary to improve the efficacy of BCG itself. Intravenous (IV) BCG ad …
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.
Han J, Gu X, Li Y, Wu Q. Han J, et al. Biomed Pharmacother. 2020 Sep;129:110393. doi: 10.1016/j.biopha.2020.110393. Epub 2020 Jun 16. Biomed Pharmacother. 2020. PMID: 32559616 Free article. Review.
At present, the widely confirmed and accepted immunity mechanism of BCG fall in the processes of the absorption after the instillation of BCG, the internalization of BCG, cytokine release induced by a series of signal transduction pathways, and the effect sta …
At present, the widely confirmed and accepted immunity mechanism of BCG fall in the processes of the absorption after the instillatio …
Novel treatments in BCG failure. Where do we stand today?
Fragkoulis C, Glykas I, Bamias A, Stathouros G, Papadopoulos G, Ntoumas K. Fragkoulis C, et al. Arch Esp Urol. 2021 Sep;74(7):681-691. Arch Esp Urol. 2021. PMID: 34472437 Free article. Review. English, Spanish.
We hereby review novel treatment modalities for BCG failure patients. METHODS: This is a narrative review. Keywords for the search were BCG failure, BCG unresponsive, BCG refractory, BCG relapsing and BCG intolerance. ...For patients in w …
We hereby review novel treatment modalities for BCG failure patients. METHODS: This is a narrative review. Keywords for the search we …
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer.
Sfakianos JP, Salome B, Daza J, Farkas A, Bhardwaj N, Horowitz A. Sfakianos JP, et al. Urol Oncol. 2021 Feb;39(2):121-129. doi: 10.1016/j.urolonc.2020.09.031. Epub 2020 Nov 28. Urol Oncol. 2021. PMID: 33262028 Review.
Recently the role of "trained immunity" has been identified as a possible mechanism for BCG vaccine-mediated immunity to Mtb. Similarly, BCG has been used as an immunotherapy for bladder cancer for more than 40 years, and the underlying mechanisms for BCG-med …
Recently the role of "trained immunity" has been identified as a possible mechanism for BCG vaccine-mediated immunity to Mtb. Similar …
Evolution and Strain Variation in BCG.
Abdallah AM, Behr MA. Abdallah AM, et al. Adv Exp Med Biol. 2017;1019:155-169. doi: 10.1007/978-3-319-64371-7_8. Adv Exp Med Biol. 2017. PMID: 29116634 Review.
Following the distribution of stocks of BCG to vaccine production laboratories around the world, it was only a few decades before different BCG producers recognized that there were variants of BCG, likely due to different passaging conditions in the different …
Following the distribution of stocks of BCG to vaccine production laboratories around the world, it was only a few decades before dif …
BCG--different strains, different vaccines?
Behr MA. Behr MA. Lancet Infect Dis. 2002 Feb;2(2):86-92. doi: 10.1016/s1473-3099(02)00182-2. Lancet Infect Dis. 2002. PMID: 11901655 Review.
Some of these genetic alterations explain certain variations in laboratory properties of BCG. However, these mutations in BCG strains have yet to be shown to affect BCG-associated protection and/or adverse effects. Continuing research is attempting to assess …
Some of these genetic alterations explain certain variations in laboratory properties of BCG. However, these mutations in BCG
[BCG vaccination].
Stögmann W. Stögmann W. Wien Med Wochenschr. 1991;141(12):265-70. Wien Med Wochenschr. 1991. PMID: 1949819 Review. German.
The complications of BCG-vaccinations are: 1. severe local reactions (esp. purulent BCG-lymphadenitis), 2. BCG-osteomyelitis and 3. BCG-sepsis. The quantity of purulent lymphadenitis is dependent from the vaccine-type; "normal" vaccines cause 0.3%, the …
The complications of BCG-vaccinations are: 1. severe local reactions (esp. purulent BCG-lymphadenitis), 2. BCG-osteomye …
BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS, Roth A, Garly ML, Fisker AB, Schaltz-Buchholzer F, Timmermann A, Berendsen M, Aaby P. Benn CS, et al. J Intern Med. 2020 Dec;288(6):614-624. doi: 10.1111/joim.13084. Epub 2020 May 25. J Intern Med. 2020. PMID: 32301189 Free article. Review.
Currently, BCG vaccination programmes use "BCG vaccination coverage by 12 months of age" as the performance indicator. ...The proportion with a BCG scar varied from 52 to 93%; the estimated effect of a BCG scar was not associated with the scar prevalen …
Currently, BCG vaccination programmes use "BCG vaccination coverage by 12 months of age" as the performance indicator. ...The …
Comparative genomics of BCG vaccines.
Behr MA. Behr MA. Tuberculosis (Edinb). 2001;81(1-2):165-8. doi: 10.1054/tube.2000.0253. Tuberculosis (Edinb). 2001. PMID: 11463238 Review.
Bacille Calmette-Guerin (BCG) vaccines have been given to more people than any other vaccine. ...With recent genomic analysis of BCG strains, it has become possible to piece together the molecular events that have resulted in current BCG vaccines. ...
Bacille Calmette-Guerin (BCG) vaccines have been given to more people than any other vaccine. ...With recent genomic analysis of B
BCG vaccination and cancer.
Grange JM, Stanford JL. Grange JM, et al. Tubercle. 1990 Mar;71(1):61-4. doi: 10.1016/0041-3879(90)90063-e. Tubercle. 1990. PMID: 2196727 Review. No abstract available.
33,553 results
You have reached the last available page of results. Please see the User Guide for more information.